Mitsuyo Maeda Selected Research

Intellectual Disability (Idiocy)

11/2019

Autophagy in the Central Nervous System and Effects of Chloroquine in Mucopolysaccharidosis Type II Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuyo Maeda Research Topics

Disease

4	Ischemia 01/2020 - 04/2003
4	Neoplasms (Cancer) 01/2019 - 02/2006
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2019 - 11/2009
2	Carcinoma (Carcinomatosis) 05/2008 - 02/2006
2	Ganglion Cysts (Ganglion) 02/2008 - 03/2007
2	Infarction (Infarctions) 11/2004 - 07/2003
1	Kidney Diseases (Kidney Disease) 07/2022
1	Aortic Dissection 01/2022
1	Thoracic Aortic Aneurysm 01/2022
1	Mucopolysaccharidosis II (Hunter Syndrome) 11/2019
1	Intellectual Disability (Idiocy) 11/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Reinfection 01/2019
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2015
1	Hyperalgesia 11/2010
1	GM1 Gangliosidosis (Gangliosidosis GM1) 11/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2008
1	Cystitis 04/2008
1	Inflammation (Inflammations) 04/2008
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 03/2007
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2007
1	Coinfection 04/2006
1	Glioma (Gliomas) 04/2006
1	Astrocytoma (Pilocytic Astrocytoma) 04/2006
1	Hyperthermia 02/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2004
1	Peripheral Nerve Injuries 11/2004
1	Brain Ischemia (Cerebral Ischemia) 11/2004
1	Dry Eye Syndromes (Dry Eye Syndrome) 07/2004
1	Cerebral Infarction 07/2003
1	Stroke (Strokes) 04/2003

Drug/Important Bio-Agent (IBA)

2	EpitopesIBA 01/2019 - 07/2004
2	Proteins (Proteins, Gene)FDA Link 04/2006 - 07/2003
2	Messenger RNA (mRNA)IBA 11/2004 - 07/2003
1	OsmiumIBA 07/2022
1	Biological ProductsIBA 07/2022
1	Angiotensin IIIBA 01/2022
1	IntegrinsIBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	GlycosaminoglycansIBA 11/2019
1	Lysergic Acid Diethylamide (LSD)IBA 11/2019
1	Chloroquine (Aralen)FDA LinkGeneric 11/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	NestinIBA 01/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015
1	cangrelorIBA 11/2010
1	Purinergic P2 Receptors (ADP Receptor)IBA 11/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2008
1	Pancreatitis-Associated ProteinsIBA 04/2008
1	PicibanilIBA 02/2008
1	Carisoprodol (Soma)FDA LinkGeneric 03/2007
1	Cholinergic Agents (Cholinergics)IBA 03/2007
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 03/2007
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2006
1	Cre recombinaseIBA 04/2006
1	Therapeutic UsesIBA 02/2006
1	damage-induced neuronal endopeptidaseIBA 11/2004
1	MucinsIBA 07/2004
1	SugarsIBA 07/2004
1	Monoclonal AntibodiesIBA 07/2004
1	Activating Transcription Factor 3IBA 07/2003
1	Transcription Factors (Transcription Factor)IBA 07/2003
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2003
1	enhanced green fluorescent proteinIBA 04/2003

Therapy/Procedure

3	Therapeutics 01/2020 - 05/2008
1	Enzyme Replacement Therapy 11/2019
1	Cell Transplantation 11/2009
1	Intravesical Administration 05/2008
1	Aftercare (After-Treatment) 02/2006
1	Radiotherapy 02/2006